The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss drug ... As a result, prescriptions of GLP-1 diabetes and weight-loss medications more than doubled between 2022 and 2023. Meanwhile, they have ...

Manufactured by Eli Lilly and Company, Zepbound offers a new approach to managing OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication ...

Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens new tab weight-loss treatment ... after COVID blow August 8, 2022 Future of Healthcategory ...

New year, new you! Getting healthy is a popular resolution and to meet goals, some people may turn to weight-loss drugs for ... those that are offering prescription drugs without a prescription ...